What to Know About the WHO’s New GLP-1 Drug Guideline
Abstract
This Medical News article discusses key learnings from new World Health Organization guidance on the use of glucagon-like peptide-1 (GLP-1) medications for the treatment of obesity in adults.
Fields of Study & Subjects
Diabetes Treatment and Management
Pharmacology and Obesity Treatment
Bariatric Surgery and Outcomes
Publication details
- Journal / source
- JAMA
- Publisher
- American Medical Association (AMA)
- Volume
- 335
- Issue
- 5
- Pages
- 388–388
- Publication date
- 9 January 2026
- Language
- EN